SCHEMBL24675411

SCHEMBL24675411

CC(N)c1cccc(OCCCCCCOCCOCCOCCCCCC(=O)O)c1

nearest known ligand 0.54

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ CYSLTR2 Q9NS75 4/20 0.54
▸ CYSLTR1 Q9Y271 4/20 0.54
▸ SMN1; SMN2 Q16637 2/20 0.49
▸ KDM4E B2RXH2 1/20 0.49
▸ ALDH1A1 P00352 1/20 0.49
▸ LMNA P02545 1/20 0.49
▸ KMT2A Q03164 2/20 0.45
▸ MEN1 O00255 1/20 0.45
▸ HDAC1 Q13547 1/20 0.44
▸ HDAC2 Q92769 1/20 0.44
▸ PLA2G4B P0C869 1/20 0.44
▸ FABP1 P07148 1/20 0.43
▸ CNR2 P34972 1/20 0.43
▸ PPARG P37231 1/20 0.43
▸ PPARA Q07869 1/20 0.43
▸ CNR1 P21554 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24675410 1.00 CYSLTR2 (0.54) CYSLTR2CYSLTR1SMN1; SMN2KDM4EALDH1A1
SCHEMBL24675791 1.00 CYSLTR2 (0.54) CYSLTR2CYSLTR1SMN1; SMN2KDM4EALDH1A1
SCHEMBL24675240 0.95 CYSLTR2 (0.54) CYSLTR2CYSLTR1SMN1; SMN2KDM4EALDH1A1
SCHEMBL24675778 0.88 SMN1; SMN2 (0.45) CYSLTR2CYSLTR1SMN1; SMN2KDM4EALDH1A1
SCHEMBL24675494 0.88 SMN1; SMN2 (0.45) CYSLTR2CYSLTR1SMN1; SMN2KDM4EALDH1A1
SCHEMBL24675493 0.88 SMN1; SMN2 (0.45) CYSLTR2CYSLTR1SMN1; SMN2KDM4EALDH1A1
SCHEMBL24675626 0.88 SMN1; SMN2 (0.49) CYSLTR2CYSLTR1SMN1; SMN2KDM4EALDH1A1
SCHEMBL24675627 0.88 SMN1; SMN2 (0.49) CYSLTR2CYSLTR1SMN1; SMN2KDM4EALDH1A1
SCHEMBL24675467 0.88 SMN1; SMN2 (0.49) CYSLTR2CYSLTR1SMN1; SMN2KDM4EALDH1A1
SCHEMBL24675246 0.86 ALDH1A1 (0.45) CYSLTR2CYSLTR1SMN1; SMN2KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022159688-A9 DEGRADERS OF GRK2 AND USES THEREOF SONATA THERAPEUTICS, INC. (US) 2023-09-21 — — WO disclosed
WO-2022159688-A1 DEGRADERS OF GRK2 AND USES THEREOF CYGNAL THERAPEUTICS, INC. (US) 2022-07-28 — — WO disclosed
Send feedback